Stockreport

Week In Review: AriBio Sells China Rights To Alzheimer's Candidate In $770M Deal [Seeking Alpha]

Nuvation Bio Inc. Class A  (NUVB) 
PDF AnHeart Therapeutics, a New York-Hangzhou biopharma, will become part of Nuvation Bio (NYSE: NUVB) of New York in an all-stock deal. San Diego's Avenzo Therapeutics c [Read more]